Suppr超能文献

来自具有抗Ro和抗La抗体母亲的中国胎儿队列中的心脏表现。

Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies.

作者信息

Wang Xin, Liu Xiao-Wei, Han Ling, Li Meng-Tao, Zhao Jiu-Liang, Sun Lin, Han Jian-Cheng, Zeng Xiao-Feng, Tian Xin-Ping, Zhao Ying, He Yi-Hua

机构信息

Echocardiography Medical Center, Maternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Department of Pediatric Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

Front Pediatr. 2022 Jul 28;10:904138. doi: 10.3389/fped.2022.904138. eCollection 2022.

Abstract

OBJECTIVES

To analyze the clinical characteristics, echocardiographic features, and prognosis of fetuses based on three groups of cardiac manifestations associated with maternal anti-Ro and anti-La antibodies in China. This study included three groups: the isolated-arrhythmia, isolated-endocardial fibroelastosis (EFE), and mixed groups.

METHODS

We prospectively evaluated 36 fetuses with cardiac manifestations due to maternal anti-Ro and anti-La antibodies from our center between 2016 and 2020 in China. Clinical and echocardiographic data were collected.

RESULTS

There were 13 patients (36%) in the isolated-arrhythmia group, eight (22%) in the isolated-EFE group, and 15 (42%) in the mixed group. All patients in the isolated-EFE group presented with mild EFE. Severe EFE was identified in four patients (27%) in the mixed group. Atrioventricular block (AVB) was more common in the isolated-arrhythmia group (13, 100%) than in the mixed group (6, 40%; = 0.001). Moderate-severe mitral regurgitation ( = 0.006), dilated cardiomyopathy (DCM, = 0.017), and low cardiovascular profile scores ( = 0.013) were more common in the mixed group than in the other two groups. Twenty-one mothers decided to terminate the pregnancy and 15 fetuses were born with regular perinatal treatment. They all survived at 1 year of age. One patient in the isolated-arrhythmia group and two in the mixed group required a pacemaker due to third-degree AVB or atrioventricular junctional rhythm. Five patients in the isolated-EFE group and five in the mixed group had no DCM or heart failure and the location of mild EFE was significantly reduced.

CONCLUSION

Fetal cardiac manifestations due to maternal anti-Ro and anti-La antibodies can be divided into three groups, i.e., the isolated-arrhythmia, isolated-EFE, and mixed groups. AVB usually occurs in the isolated-arrhythmia group. Severe EFE, moderate-severe mitral regurgitation, and DCM mainly appear in the mixed group. Location of mild EFE significantly reduces after birth and the outcome of fetuses with mild EFE depends on the presence of arrhythmia and its subtypes.

摘要

目的

基于中国与母体抗Ro和抗La抗体相关的三组心脏表现,分析胎儿的临床特征、超声心动图特征及预后。本研究包括三组:孤立性心律失常组、孤立性心内膜弹力纤维增生症(EFE)组和混合组。

方法

我们前瞻性评估了2016年至2020年期间在中国本中心的36例因母体抗Ro和抗La抗体而出现心脏表现的胎儿。收集了临床和超声心动图数据。

结果

孤立性心律失常组有13例患者(36%),孤立性EFE组有8例(22%),混合组有15例(42%)。孤立性EFE组的所有患者均表现为轻度EFE。混合组中有4例患者(27%)被诊断为重度EFE。房室传导阻滞(AVB)在孤立性心律失常组(13例,100%)中比在混合组(6例,40%;P = 0.001)中更常见。中度至重度二尖瓣反流(P = 0.006)、扩张型心肌病(DCM,P = 0.017)和低心血管轮廓评分(P = 0.013)在混合组中比在其他两组中更常见。21位母亲决定终止妊娠,15例胎儿在接受常规围产期治疗后出生。他们在1岁时均存活。孤立性心律失常组有1例患者,混合组有2例患者因三度AVB或房室交界性心律需要起搏器。孤立性EFE组有5例患者,混合组有5例患者没有DCM或心力衰竭,轻度EFE的范围明显缩小。

结论

因母体抗Ro和抗La抗体导致的胎儿心脏表现可分为三组,即孤立性心律失常组、孤立性EFE组和混合组。AVB通常发生在孤立性心律失常组。重度EFE、中度至重度二尖瓣反流和DCM主要出现在混合组。轻度EFE在出生后范围明显缩小,轻度EFE胎儿的预后取决于心律失常的存在及其亚型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971d/9371606/b8782d48ef0d/fped-10-904138-g0001.jpg

相似文献

1
Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies.
Front Pediatr. 2022 Jul 28;10:904138. doi: 10.3389/fped.2022.904138. eCollection 2022.
3
Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
Circulation. 2002 Feb 19;105(7):843-8. doi: 10.1161/hc0702.104182.
7
Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies.
Clin Rheumatol. 2019 Aug;38(8):2211-2217. doi: 10.1007/s10067-019-04556-8. Epub 2019 Apr 17.
8
Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):167-71. doi: 10.1016/j.ejogrb.2005.01.013.

引用本文的文献

1
Ultrasonographic characterization and prognostic follow-up of fetal cardiac involvement in maternal immune diseases.
Front Med (Lausanne). 2025 Jun 16;12:1564873. doi: 10.3389/fmed.2025.1564873. eCollection 2025.

本文引用的文献

1
Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored.
Front Pharmacol. 2022 Jan 20;13:820760. doi: 10.3389/fphar.2022.820760. eCollection 2022.
2
Cohort study of congenital complete heart block among preterm neonates: a single-center experience over a 15-year period.
Eur J Pediatr. 2022 Mar;181(3):1047-1054. doi: 10.1007/s00431-021-04293-8. Epub 2021 Oct 27.
3
An Overview of Neonatal Lupus with Anti-Ro Characteristics.
Int J Mol Sci. 2021 Aug 27;22(17):9281. doi: 10.3390/ijms22179281.
6
Maternal steroid therapy for fetuses with immune-mediated complete atrioventricular block: a systematic review and meta-analysis.
J Matern Fetal Neonatal Med. 2019 Jun;32(11):1884-1892. doi: 10.1080/14767058.2017.1419182. Epub 2018 Oct 11.
7
Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.
Int J Cardiol. 2017 Dec 1;248:263-269. doi: 10.1016/j.ijcard.2017.07.100. Epub 2017 Aug 7.
8
Fluorinated steroids do not improve outcome of isolated atrioventricular block.
Int J Cardiol. 2016 Dec 15;225:167-171. doi: 10.1016/j.ijcard.2016.09.119. Epub 2016 Sep 30.
10
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.
Autoimmun Rev. 2015 Dec;14(12):1154-60. doi: 10.1016/j.autrev.2015.08.005. Epub 2015 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验